May 27 (Reuters) - Sprint Bioscience AB SPRINT.ST:
Q1 NET SALES SEK 14.1 (17.9) MILLION
Q1 OPERATING RESULT SEK -5.0 MILLION
DUE TO DISCONTINUATION OF THE VRK1 PROGRAMME, CO WILL LAY OFF ABOUT 35 PERCENT OF ITS WORKFORCE
ON FULL-YEAR BASIS, TOTAL COST REDUCTIONS EXPECTED TO ABOUT SEK 30 MILLION, OF WHICH ABOUT SEK 10 MILLION RELATES TO PERSONNEL COSTS
THE FULL IMPACT OF THE SAVINGS WILL BE VISIBLE IN THE THIRD QUARTER OF 2025
Source text: ID:nMFN9SW17y
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))